acetylcarnitine has been researched along with oxidopamine in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aloe, L; De Simone, R; Ferraris, L; Ramacci, MT | 1 |
| Mishra, A; Shukla, S; Singh, S | 1 |
| Mishra, A; Shukla, R; Shukla, S; Singh, S; Srivastava, N | 1 |
| Afshin-Majd, S; Baluchnejadmojarad, T; Bashiri, K; Kiasalari, Z; Roghani, M; Sedaghat, R | 1 |
| Mishra, A; Mishra, SK; Shukla, S; Singh, S | 1 |
5 other study(ies) available for acetylcarnitine and oxidopamine
| Article | Year |
|---|---|
Levocarnitine acetyl treatment promotes iris reinnervation following 6-hydroxydopamine-induced noradrenergic denervation in rats.
Topics: Acetylcarnitine; Adrenergic Fibers; Animals; Animals, Newborn; Iris; Nerve Regeneration; Neurites; Oxidopamine; Rats; Rats, Sprague-Dawley; Sympathectomy, Chemical | 1992 |
ALCAR Exerts Neuroprotective and Pro-Neurogenic Effects by Inhibition of Glial Activation and Oxidative Stress via Activation of the Wnt/β-Catenin Signaling in Parkinsonian Rats.
Topics: Acetylcarnitine; Animals; Antioxidants; Ataxia; Axons; Behavior, Animal; Brain; Cell Nucleus; Disease Models, Animal; Dopaminergic Neurons; Glycogen Synthase Kinase 3 beta; Lipid Peroxidation; Male; Neural Stem Cells; Neurogenesis; Neuroglia; Neuroprotective Agents; Nitrites; Oxidative Stress; Oxidopamine; Parkinson Disease; Phenotype; Phosphorylation; Rats, Sprague-Dawley; Reactive Oxygen Species; Wnt Signaling Pathway | 2016 |
Acetyl-L-Carnitine via Upegulating Dopamine D1 Receptor and Attenuating Microglial Activation Prevents Neuronal Loss and Improves Memory Functions in Parkinsonian Rats.
Topics: Acetylcarnitine; Animals; Cell Line; Dopaminergic Neurons; Excitatory Amino Acid Transporter 2; Gliosis; Glutathione; Inflammation Mediators; Male; Memory; Microglia; Motor Activity; Neurons; Neuroprotection; Nitric Oxide Synthase Type II; Oxidative Stress; Oxidopamine; Parkinson Disease; Rats, Sprague-Dawley; Receptors, Dopamine D1; Up-Regulation | 2018 |
Acetyl-l-carnitine protects dopaminergic nigrostriatal pathway in 6-hydroxydopamine-induced model of Parkinson's disease in the rat.
Topics: Acetylcarnitine; Animals; Apomorphine; Behavior, Animal; Corpus Striatum; Dopamine Agonists; Dopaminergic Neurons; Inflammation; Male; Neural Pathways; Nootropic Agents; Oxidative Stress; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Wistar; Substantia Nigra; Sympatholytics | 2017 |
ALCAR promote adult hippocampal neurogenesis by regulating cell-survival and cell death-related signals in rat model of Parkinson's disease like-phenotypes.
Topics: Acetylcarnitine; Animals; Cell Death; Cell Survival; Hippocampus; Male; Neurogenesis; Nootropic Agents; Oxidopamine; Parkinsonian Disorders; Phenotype; Rats; Rats, Sprague-Dawley | 2017 |